BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37442303)

  • 21. Applications of chemical exchange saturation transfer magnetic resonance imaging in identifying genetic markers in gliomas.
    Jiang S; Wen Z; Ahn SS; Cai K; Paech D; Eberhart CG; Zhou J
    NMR Biomed; 2023 Jun; 36(6):e4731. PubMed ID: 35297117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amide proton transfer imaging for differentiation of tuberculomas from high-grade gliomas: Preliminary experience.
    Kulanthaivelu K; Jabeen S; Saini J; Raju S; Nalini A; Sadashiva N; Hegde S; Rolla NK; Saha I; M N; Vengalil S; Swaroop S; Rao S
    Neuroradiol J; 2021 Oct; 34(5):440-448. PubMed ID: 33823712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3D Amide Proton Transfer-Weighted Imaging for Grading Glioma and Correlating IDH Mutation Status: Added Value to 3D Pseudocontinuous Arterial Spin Labelling Perfusion.
    Hou H; Chen W; Diao Y; Wang Y; Zhang L; Wang L; Xu M; Yu J; Song T; Liu Y; Yuan Z
    Mol Imaging Biol; 2023 Apr; 25(2):343-352. PubMed ID: 35962302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contributors to contrast between glioma and brain tissue in chemical exchange saturation transfer sensitive imaging at 3 Tesla.
    Scheidegger R; Wong ET; Alsop DC
    Neuroimage; 2014 Oct; 99():256-68. PubMed ID: 24857712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CEST imaging of the APT and ssMT predict the overall survival of patients with glioma at the first follow-up after completion of radiotherapy at 3T.
    von Knebel Doeberitz N; Kroh F; Breitling J; König L; Maksimovic S; Graß S; Adeberg S; Scherer M; Unterberg A; Bendszus M; Wick W; Bachert P; Debus J; Ladd ME; Schlemmer HP; Korzowski A; Goerke S; Paech D
    Radiother Oncol; 2023 Jul; 184():109694. PubMed ID: 37150450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amide proton transfer-weighted imaging of pediatric brainstem glioma and its predicted value for H3 K27 alteration.
    Cheng D; Zhuo Z; Zhang P; Qu L; Duan Y; Xu X; Xie C; Liu X; Haller S; Barkhof F; Zhang L; Liu Y
    Acta Radiol; 2023 Nov; 64(11):2922-2930. PubMed ID: 37722801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic Evaluation of Amide Proton Chemical Exchange Saturation Transfer at 3 T: Effects of Protein Concentration, pH, and Acquisition Parameters.
    Schmidt H; Schwenzer NF; Gatidis S; Küstner T; Nikolaou K; Schick F; Martirosian P
    Invest Radiol; 2016 Oct; 51(10):635-46. PubMed ID: 27272542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of Early Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer Using Amide Proton Transfer-weighted Chemical Exchange Saturation Transfer MRI: A Pilot Study.
    Zhang S; Rauch GM; Adrada BE; Boge M; Mohamed RMM; Abdelhafez AH; Son JB; Sun J; Elshafeey NA; White JB; Musall BC; Miyoshi M; Wang X; Kotrotsou A; Wei P; Hwang KP; Ma J; Pagel MD
    Radiol Imaging Cancer; 2021 Sep; 3(5):e200155. PubMed ID: 34477453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades.
    Togao O; Yoshiura T; Keupp J; Hiwatashi A; Yamashita K; Kikuchi K; Suzuki Y; Suzuki SO; Iwaki T; Hata N; Mizoguchi M; Yoshimoto K; Sagiyama K; Takahashi M; Honda H
    Neuro Oncol; 2014 Mar; 16(3):441-8. PubMed ID: 24305718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct radiofrequency saturation corrected amide proton transfer tumor MRI at 3T.
    Wu Y; Chen Y; Zhao Y; Yang S; Zhao J; Zhou J; Chen Z; Sun PZ; Zheng H
    Magn Reson Med; 2019 Apr; 81(4):2710-2719. PubMed ID: 30390326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amide Proton Transfer Imaging of Diffuse Gliomas: Effect of Saturation Pulse Length in Parallel Transmission-Based Technique.
    Togao O; Hiwatashi A; Keupp J; Yamashita K; Kikuchi K; Yoshiura T; Yoneyama M; Kruiskamp MJ; Sagiyama K; Takahashi M; Honda H
    PLoS One; 2016; 11(5):e0155925. PubMed ID: 27227746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic performance between MR amide proton transfer (APT) and diffusion kurtosis imaging (DKI) in glioma grading and IDH mutation status prediction at 3 T.
    Xu Z; Ke C; Liu J; Xu S; Han L; Yang Y; Qian L; Liu X; Zheng H; Lv X; Wu Y
    Eur J Radiol; 2021 Jan; 134():109466. PubMed ID: 33307459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amide Proton Transfer Imaging Allows Detection of Glioma Grades and Tumor Proliferation: Comparison with Ki-67 Expression and Proton MR Spectroscopy Imaging.
    Su C; Liu C; Zhao L; Jiang J; Zhang J; Li S; Zhu W; Wang J
    AJNR Am J Neuroradiol; 2017 Sep; 38(9):1702-1709. PubMed ID: 28729292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-parametric Z-spectral MRI may have a good performance for glioma stratification in clinical patients.
    Su C; Xu S; Lin D; He H; Chen Z; Damen FC; Ke C; Lv X; Cai K
    Eur Radiol; 2022 Jan; 32(1):101-111. PubMed ID: 34272981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Machine Learning-Based Multiparametric Magnetic Resonance Imaging Radiomics for Prediction of H3K27M Mutation in Midline Gliomas.
    Kandemirli SG; Kocak B; Naganawa S; Ozturk K; Yip SSF; Chopra S; Rivetti L; Aldine AS; Jones K; Cayci Z; Moritani T; Sato TS
    World Neurosurg; 2021 Jul; 151():e78-e85. PubMed ID: 33819703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical exchange saturation transfer (CEST) signal intensity at 7T MRI of WHO IV° gliomas is dependent on the anatomic location.
    Dreher C; Oberhollenzer J; Meissner JE; Windschuh J; Schuenke P; Regnery S; Sahm F; Bickelhaupt S; Bendszus M; Wick W; Unterberg A; Zaiss M; Bachert P; Ladd ME; Schlemmer HP; Radbruch A; Paech D
    J Magn Reson Imaging; 2019 Mar; 49(3):777-785. PubMed ID: 30133046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amide proton transfer weighted imaging in pediatric neuro-oncology: initial experience.
    Obdeijn IV; Wiegers EC; Alic L; Plasschaert SLA; Kranendonk MEG; Hoogduin HM; Klomp DWJ; Wijnen JP; Lequin MH
    NMR Biomed; 2024 Jun; 37(6):e5122. PubMed ID: 38369653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applying amide proton transfer-weighted MRI to distinguish pseudoprogression from true progression in malignant gliomas.
    Ma B; Blakeley JO; Hong X; Zhang H; Jiang S; Blair L; Zhang Y; Heo HY; Zhang M; van Zijl PC; Zhou J
    J Magn Reson Imaging; 2016 Aug; 44(2):456-62. PubMed ID: 26788865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of Amide proton transfer weighted (APTw) MRI for pre-surgical prediction of final diagnosis in gliomas.
    Durmo F; Rydhög A; Testud F; Lätt J; Schmitt B; Rydelius A; Englund E; Bengzon J; van Zijl P; Knutsson L; Sundgren PC
    PLoS One; 2020; 15(12):e0244003. PubMed ID: 33373375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Learning-based analysis of amide proton transfer-weighted MRI to identify true progression in glioma patients.
    Guo P; Unberath M; Heo HY; Eberhart CG; Lim M; Blakeley JO; Jiang S
    Neuroimage Clin; 2022; 35():103121. PubMed ID: 35905666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.